GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » 1-Year ROIIC %

LSB (LakeShore Biopharma Co) 1-Year ROIIC % : -1,547.91% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. LakeShore Biopharma Co's 1-Year ROIIC % for the quarter that ended in Mar. 2024 was -1,547.91%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for LakeShore Biopharma Co's 1-Year ROIIC % or its related term are showing as below:

LSB's 1-Year ROIIC % is ranked worse than
94.37% of 1422 companies
in the Biotechnology industry
Industry Median: -11.235 vs LSB: -1547.91

LakeShore Biopharma Co 1-Year ROIIC % Historical Data

The historical data trend for LakeShore Biopharma Co's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co 1-Year ROIIC % Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24
1-Year ROIIC %
- 9.32 -48.17 -1,547.91

LakeShore Biopharma Co Quarterly Data
Mar21 Sep21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Mar24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only - -48.17 - 131.95 -1,547.91

Competitive Comparison of LakeShore Biopharma Co's 1-Year ROIIC %

For the Biotechnology subindustry, LakeShore Biopharma Co's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LakeShore Biopharma Co's 1-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's 1-Year ROIIC % falls into.



LakeShore Biopharma Co 1-Year ROIIC % Calculation

LakeShore Biopharma Co's 1-Year ROIIC % for the quarter that ended in Mar. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -35.4008002 (Mar. 2024) - -15.3553565 (Mar. 2023) )/( 146.481 (Mar. 2024) - 145.186 (Mar. 2023) )
=-20.0454437/1.295
=-1,547.91%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


LakeShore Biopharma Co  (NAS:LSB) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


LakeShore Biopharma Co 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


LakeShore Biopharma Co Business Description

Traded in Other Exchanges
Address
38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.